| Somatic RHOA mutation in angioimmunoblastic T cell lymphoma M Sakata-Yanagimoto, T Enami, K Yoshida, Y Shiraishi, R Ishii, Y Miyake, ... Nature genetics 46 (2), 171-175, 2014 | 701 | 2014 |
| Frequent BCOR aberrations in extranodal NK/T‐Cell lymphoma, nasal type A Dobashi, N Tsuyama, R Asaka, Y Togashi, K Ueda, S Sakata, S Baba, ... Genes, Chromosomes and Cancer 55 (5), 460-471, 2016 | 127 | 2016 |
| Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects N Tsuyama, K Sakamoto, S Sakata, A Dobashi, K Takeuchi Journal of clinical and experimental hematopathology 57 (3), 120-142, 2017 | 108 | 2017 |
| BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation N Tsuyama, S Sakata, S Baba, Y Mishima, N Nishimura, K Ueda, ... Blood, The Journal of the American Society of Hematology 130 (4), 489-500, 2017 | 91 | 2017 |
| Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response K Sakamoto, R Katayama, R Asaka, S Sakata, S Baba, H Nakasone, ... Leukemia 32 (12), 2590-2603, 2018 | 72 | 2018 |
| Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas K Nakano, S Takahashi, T Yuasa, N Nishimura, Y Mishima, S Sakajiri, ... Japanese Journal of Clinical Oncology 42 (8), 697-703, 2012 | 50 | 2012 |
| Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis D Kaji, Y Ota, Y Sato, K Nagafuji, Y Ueda, M Okamoto, Y Terasaki, ... Blood Advances 4 (18), 4442-4450, 2020 | 37 | 2020 |
| ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern K Sakamoto, H Nakasone, Y Togashi, S Sakata, N Tsuyama, S Baba, ... International journal of hematology 103, 399-408, 2016 | 37 | 2016 |
| Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas N Tsuyama, D Ennishi, M Yokoyama, S Baba, R Asaka, Y Mishima, ... Oncotarget 8 (20), 33487, 2017 | 33 | 2017 |
| Prognostic significance of programmed cell death‐1‐positive cells in follicular lymphoma patients may alter in the rituximab era H Takahashi, N Tomita, S Sakata, N Tsuyama, C Hashimoto, R Ohshima, ... European Journal of Haematology 90 (4), 286-290, 2013 | 29 | 2013 |
| Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma Y Kusano, M Yokoyama, Y Terui, N Nishimura, Y Mishima, K Ueda, ... Blood cancer journal 7 (4), e558-e558, 2017 | 27 | 2017 |
| Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma H Nitta, Y Terui, M Yokoyama, Y Mishima, N Nishimura, K Ueda, ... Haematologica 100 (1), 87, 2015 | 22 | 2015 |
| MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy E Yamamoto, N Tomita, S Sakata, N Tsuyama, K Takeuchi, Y Nakajima, ... Cancer Science 104 (12), 1670-1674, 2013 | 20 | 2013 |
| R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma Y Mishima, Y Terui, M Yokoyama, N Nishimura, S Sakajiri, K Ueda, ... Experimental Hematology & Oncology 1, 1-6, 2012 | 20 | 2012 |
| Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma K Suzuki, Y Terui, N Nishimura, Y Mishima, S Sakajiri, M Yokoyama, ... Japanese journal of clinical oncology 43 (1), 37-44, 2013 | 19 | 2013 |
| TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis A Dobashi, Y Togashi, N Tanaka, M Yokoyama, N Tsuyama, S Baba, ... Oncotarget 9 (28), 19555, 2018 | 18 | 2018 |
| Biweekly THP‐COP therapy for newly diagnosed peripheral T‐cell lymphoma patients N Tomita, F Kodama, N Tsuyama, S Sakata, K Takeuchi, D Ishibashi, ... Hematological Oncology 33 (1), 9-14, 2015 | 18 | 2015 |
| Intravascular large B-cell lymphoma of the bilateral ovaries and uterus in an asymptomatic patient with at (11; 22)(q23; q11) constitutional translocation Y Shigematsu, M Matsuura, N Nishimura, N Tsuyama, K Takeuchi, Y Terui, ... Internal Medicine 55 (21), 3169-3174, 2016 | 16 | 2016 |
| A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement K Takeuchi, S Sakata, R Asaka, N Tsuyama, A Dobashi, M Noguchi haematologica 98 (3), e32, 2013 | 14 | 2013 |
| Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy K Ueda, Y Terui, M Yokoyama, S Sakajiri, N Nishimura, N Tsuyama, ... Leukemia & lymphoma 54 (9), 1928-1933, 2013 | 13 | 2013 |
Kengo TakeuchiCancer Institute, Japanese Foundation for Cancer Research在 umin.net 的电子邮件经过验证
